Table 2. Summary of patient, tumour and treatment characteristics by age (years) of patient.
<40 | 40–49 | 50–59 | 60–69 | 70+ | |
---|---|---|---|---|---|
Number of patients | 149 | 304 | 194 | 89 | 14 |
Pathological size (mean) (mm) | 23.0 | 23.6 | 21.6 | 24.4 | 29.2 |
% T1 | 33 | 32 | 41 | 38 | 29 |
% T2 | 61 | 59 | 54 | 55 | 64 |
% node negative | 45 | 30 | 30 | 24 | 14 |
% 1–3 node positive | 48 | 52 | 58 | 53 | 43 |
% 4–9 node positive | 6 | 15 | 11 | 15 | 21 |
% grade 3 | 75 | 65 | 61 | 71 | 85 |
% ER positive/rich | 38 | 54 | 55 | 43 | 50 |
% given tamoxifen | 40 | 45 | 58 | 68 | 83 |
% post menopausal | 3 | 6 | 51 | 100 | 100 |
% mastectomy | 36 | 40 | 41 | 44 | 50 |
% mastectomy patients given radiation therapy | 53 | 61 | 46 | 69 | 71 |
% completed six courses | 93 | 93 | 94 | 92 | 79 |
% achieving 85% dose intensity | 23 | 21 | 23 | 11 | 9 |
5-year survival (%) | 65.5 | 78.9 | 78.9 | 70 | 68.3 |
ER, Oestrogen receptor; XRT, Radiotherapy.